BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30636946)

  • 61. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
    Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
    Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries.
    Castanon A; Landy R; Michalopoulos D; Bhudia R; Leaver H; Qiao YL; Zhao F; Sasieni P
    J Glob Oncol; 2017 Oct; 3(5):524-538. PubMed ID: 29094092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytohistological discrepancies of cervico-vaginal smears and HPV status.
    Alanbay İ; Öztürk M; Fıratlıgil FB; Karaşahin KE; Yenen MC; Bodur S
    Ginekol Pol; 2017; 88(5):235-238. PubMed ID: 28580567
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Overall accuracy of cervical cytology and clinicopathological significance of LSIL cells in ASC-H cytology.
    Kim SH; Lee JM; Yun HG; Park US; Hwang SU; Pyo JS; Sohn JH
    Cytopathology; 2017 Feb; 28(1):16-23. PubMed ID: 27245707
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.
    Iftner T; Becker S; Neis KJ; Castanon A; Iftner A; Holz B; Staebler A; Henes M; Rall K; Haedicke J; von Weyhern CH; Clad A; Brucker S; Sasieni P
    J Clin Microbiol; 2015 Aug; 53(8):2509-16. PubMed ID: 26019212
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
    Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
    PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile.
    Ferreccio C; Barriga MI; Lagos M; Ibáñez C; Poggi H; González F; Terrazas S; Katki HA; Núñez F; Cartagena J; Van De Wyngard V; Viñales D; Brañes J
    Int J Cancer; 2013 Feb; 132(4):916-23. PubMed ID: 22684726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo.
    Mahmud SM; Sangwa-Lugoma G; Nasr SH; Kayembe PK; Tozin RR; Drouin P; Lorincz A; Ferenczy A; Franco EL
    Gynecol Oncol; 2012 Feb; 124(2):286-91. PubMed ID: 22062546
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening.
    Depuydt CE; Makar AP; Ruymbeke MJ; Benoy IH; Vereecken AJ; Bogers JJ
    Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):628-37. PubMed ID: 21297040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I.
    Wu R; Belinson SE; Du H; Na W; Qu X; Wu R; Liu Y; Wang C; Zhou Y; Zhang L; Belinson JL
    Int J Gynecol Cancer; 2010 Nov; 20(8):1411-4. PubMed ID: 21051986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting.
    McAdam M; Sakita J; Tarivonda L; Pang J; Frazer IH
    PLoS One; 2010 Oct; 5(10):e13266. PubMed ID: 20949059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
    Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS
    Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo.
    Hovland S; Arbyn M; Lie AK; Ryd W; Borge B; Berle EJ; Skomedal H; Kadima TM; Kyembwa L; Billay EM; Mukwege D; Chirimwami RB; Mvula TM; Snijders PJ; Meijer CJ; Karlsen F
    Br J Cancer; 2010 Mar; 102(6):957-65. PubMed ID: 20197765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical results of the liquid-based cervical cytology tool, Liqui-PREP, in comparison with conventional smears for detection of squamous cell abnormalities.
    Canda MT; Demir N; Sezer O; Doganay L; Ortac R
    Asian Pac J Cancer Prev; 2009; 10(3):399-402. PubMed ID: 19640181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program.
    Beerman H; van Dorst EB; Kuenen-Boumeester V; Hogendoorn PC
    Gynecol Oncol; 2009 Mar; 112(3):572-6. PubMed ID: 19150573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Different cervical cancer screening approaches in a Chinese multicentre study.
    Li N; Shi JF; Franceschi S; Zhang WH; Dai M; Liu B; Zhang YZ; Li LK; Wu RF; De Vuyst H; Plummer M; Qiao YL; Clifford G
    Br J Cancer; 2009 Feb; 100(3):532-7. PubMed ID: 19127262
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of conventional Papanicolaou smears and fluid-based, thin-layer cytology with colposcopic biopsy control in central Italy: a consecutive sampling study of 461 cases.
    Rahimi S; Carnovale-Scalzo C; Marani C; Renzi C; Malvasi A; Votano S
    Diagn Cytopathol; 2009 Jan; 37(1):1-3. PubMed ID: 18973131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.